Abiopharma

🔍 Crosswhite Mark A. (Director)

Company: REGIONS FINANCIAL CORP (RF)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 1,122 shares of Phantom Stock (Derivative)
  Date: 2026-04-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 22,097.91 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3, F4

Footnotes:

• F1: Each share of phantom stock represents the right to the cash value of one share of Regions' common stock.
• F2: The reporting person has elected to receive shares of phantom stock in lieu of cash compensation payable pursuant to Regions' Director Compensation Program. The shares of phantom stock are accrued under Regions' Directors' Deferred Investment Plan on the date such fees would otherwise be payable (i.e., quarterly, in arrears).
• F3: Shares of phantom stock are payable in cash in a lump sum or up to 10 annual installments, at the election of the reporting person, within 30 days after the close of the plan year in which the reporting person terminates service as a director.
• F4: Includes quarterly cash dividends that have been deemed reinvested in phantom stock.